Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Olga Gawrys

Olga Gawrys

Mossakowski Medical Research Centre PAS, Poland

Title: Cationic derivatives of polyisoprenoid alcohols for liposomal drug delivery

Biography

Biography: Olga Gawrys

Abstract

Polyisoprenoids represent a large and diverse class of naturally occurring hydrophobic polymers, found in almost all living organisms. These linear compounds, constructed of 5 to more than 150 isoprene units, are commonly divided into dolichols (with hydrogenated α-bond) and α-unsaturated polyprenols. Polyisoprenoid alcohols play numerous roles in cells but above all, as structural components of cellular membranes, they modulate their properties. Biophysical studies proved that polyisoprenoids act as membrane modulators by influencing their fluidity and permeability. Latest research demonstrated that semi-synthetic, cationic derivatives of polyisoprenoid alcohols (called amino-prenols, APrens) possess lipofecting properties, because they facilitate the transfer of genetic material towards the cells. Amino-prenols were obtained by chemical modification in that hydroxyl group on α end was replaced by a quaternary ammonium group. This generated specific properties whereby these cationic lipids can influence biological membranes more easily and effectively. Hence the idea to use amino-prenols as components of liposomal carriers of drugs and genetic material. In the first stage of our study we tested potential toxicity of novel carriers with particular emphasis on their impact on renal function. In the next steps we examined usefulness of newly designed carriers for liposomal delivery of various drugs. Obtained results lead us to suspect that amino-prenols can be used as components of drug carriers, not only augmenting the biodistribution of active substances, but also improving the stability and loading capacity of liposomes. In the future we plan to further study amino-prenols in an attempt to enhance gene expression in vivo.